Helen Pearce Dr Emma Montgomery Professor Neil Sheerin
| A Novel Case of CMV Resistance to Valganciclovir and Maribavir in a Renal Transplant Patient | 2024 |
|
Dr George Kourounis Robin Nandi Dr Sam Tingle Dr Emily Glover Emily Thompson et al. | Deep Learning for Automated Boundary Detection and Segmentation in Organ Donation Photography | 2024 |
|
Dr Sally Johnson Professor David Kavanagh Professor John Sayer Dr Edwin Wong Megan Bates et al. | Description and Cross-Sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort | 2024 |
|
Emily Glover Professor David Kavanagh Professor Neil Sheerin
| Kidney Transplantation in Patients with aHUS: A Comparison of Eculizumab Prophylaxis Versus Rescue Therapy | 2024 |
|
Professor David Kavanagh Dr Vicky Brocklebank Professor Neil Sheerin
| Outcomes from the International Society of Nephrology Haemolytic Uraemic Syndromes International Forum | 2024 |
|
Phil Mawson Dr Guy MacGowan Professor Neil Sheerin Professor Andrew Fisher Professor James Shaw et al. | SIGNET: protocol for a multicentre, single-blind prospective, group sequential, randomised controlled trial to evaluate the benefits of a single dose of simvastatin given to potential organ donors declared dead by neurological criteria on outcomes in organ recipients | 2024 |
|
Dr Edwin Wong Lee-Ann Naidoo Sarah Winn Dr Patrick Walsh Dr Vicky Brocklebank et al. | The Annual Report of the National Renal Complement Therapeutics Centre 2022/23 | 2024 |
|
Emily Glover Dr Kate Smith-Jackson Dr Vicky Brocklebank Dr Valerie Wilson Dr Patrick Walsh et al. | Assessing the Impact of Prophylactic Eculizumab on Renal Graft Survival in Atypical Hemolytic Uremic Syndrome | 2023 |
|
Dr Vicky Brocklebank Dr Patrick Walsh Dr Kate Smith-Jackson Dr Thomas Hallam Professor Kevin Marchbank et al. | Atypical haemolytic uraemic syndrome in the era of terminal complement inhibition- An observational cohort study | 2023 |
|
Dr Beth Gibson Chloe Connelly Dr Salta Moldakhmetova Professor Neil Sheerin
| Complement activation and kidney transplantation; a complex relationship | 2023 |
|
Dr Georgie Wilkins Dr Jenny Gilmour Eirini Giannoudaki Emeritus Professor John Kirby Professor Neil Sheerin et al. | Dissecting the Therapeutic Mechanisms of Sphingosine-1-Phosphate Receptor Agonism during Ischaemia and Reperfusion | 2023 |
|
Sarah Thompson Chong Pang Dr Tom Hellyer Dr Jonathan Scott Professor John Simpson et al. | Nitration of Chemokine CXCL8 acts as a natural mechanism to limit acute inflammation | 2023 |
|
Dr Ruyue Sun Dr Long Xie Rebecca Russell Dr Edwin Wong Professor Neil Sheerin et al. | Pre-eclampsia is associated with complement pathway activation in the maternal and fetal circulation, and placental tissue | 2023 |
|
Dr Edwin Wong Sarah Winn Dr Michal Malina Dr Sally Johnson Professor Neil Sheerin et al. | The Annual Report of the National Renal Complement Therapeutics Centre 2021/22 | 2023 |
|
Professor Neil Sheerin
| Comparative efficacy of ravulizumab and eculizumab in the treatment of atypical hemolytic uremic syndrome: an indirect comparison using clinical trial data | 2022 |
|
Emily Thompson Dr Avinash Sewpaul Lucy Bates Dr Sam Tingle Dr Aldi Situmorang et al. | MicroRNA antagonist therapy during normothermic machine perfusion of donor kidneys | 2022 |
|
Professor Neil Sheerin
| Research engagement by British early-career practitioners in nephrology: A multidisciplinary survey | 2022 |
|
Sarah Dunn Abishek Umashankar Andrew Bryant Dr Sonya Carnell Dr Thomas Chadwick et al. | Saftey and impact of eculizumab withdrawal in patients with atypical haemolytic uraemic syndrome: protocol for a multicentre, open-label, prospective, single-arm study | 2022 |
|
Professor Neil Sheerin
| A pilot study evaluating GSK1070806 inhibition of interleukin-18 in renal transplant delayed graft function | 2021 |
|
Dr Emily Thompson Chloe Connelly Professor Simi Ali Professor Neil Sheerin Professor Colin Wilson et al. | Cell therapy during machine perfusion | 2021 |
|
Nina Jordan Dr Sam Tingle Victoria Shuttleworth Katie Cooke Dr Rachael Redgrave et al. | MiR-126-3p Is Dynamically Regulated in Endothelial-to-Mesenchymal Transition during Fibrosis | 2021 |
|
Dr Jehill Parikh Professor Peter Thelwall Professor Neil Sheerin
| Motion correction of free-breathing magnetic resonance renography using model-driven registration | 2021 |
|
Dr Emily Thompson Lucy Bates Dr Ibrahim Ibrahim Dr Avinash Sewpaul Rodrigo Figueiredo et al. | Novel delivery of cellular therapy to reduce ischaemia reperfusion injury in kidney transplantation | 2021 |
|
Dr Edwin Wong Sarah Winn Dr Michal Malina Dr Sally Johnson Professor Neil Sheerin et al. | The Annual Report of the National Renal Complement Therapeutics Centre 2020/21 | 2021 |
|
Dr Tom Altmann Dr Stephen Owens Dr Dipayan Mitra Professor Neil Sheerin Professor David Kavanagh et al. | Complement Factor I deficiency: a potentially treatable cause of fulminant cerebral inflammation | 2020 |
|
Dr Jack Leslie Dr Marina Garcia Macia Dr Saimir Luli Dr Julie Worrell William Reilly et al. | c-Rel orchestrates energy-dependant epithelial and macrophage reprogramming in fibrosis | 2020 |
|
Dr Sam Tingle Dr Avinash Sewpaul Lucy Bates Dr Emily Thompson Victoria Shuttleworth et al. | Dual microRNA blockade increases expression of antioxidant protective proteins; implications for ischaemia reperfusion injury | 2020 |
|
Emily Glover Dr Ally Speight Dr Despina Televantou Dr Stephanie Needham Professor Neil Sheerin et al. | Immunosuppression-induced clonal T-cell lymphoproliferative disease causing severe diarrhoea mimicking coeliac disease following renal transplantation: a case report | 2020 |
|
Professor Neil Sheerin
| KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation. | 2020 |
|
Dr Vicky Brocklebank Dr Kate Smith-Jackson Dr Patrick Walsh Professor Kevin Marchbank Professor Claire Harris et al. | Long-term outcomes and response to treatment in DGKE nephropathy | 2020 |
|
Dr Ian Logan Dr Charlie Tomson Professor Neil Sheerin Dr Tim Ellam
| Obesity, Sex, Race, and Early Onset Hypertension: Implications for a Refined Investigation Strategy | 2020 |
|
Professor Neil Sheerin
| Summary of the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation | 2020 |
|
Dr Edwin Wong Lisa Batchelor Dr Michal Malina Dr Sally Johnson Professor Neil Sheerin et al. | The Annual Report of the National Renal Complement Therapeutics Centre 2019/20 | 2020 |
|
Dr Gareth Parry Professor John Dark Professor Neil Sheerin
| The Impact of Severe Acute Kidney Injury Requiring Renal Replacement Therapy on Survival and Renal Function of Heart Transplant Recipients – A UK Cohort Study | 2020 |
|
Dr Jamie Willows Professor Neil Sheerin
| The role of complement in kidney disease | 2020 |
|
Beatriz Martinez Burgo Emeritus Professor John Kirby Professor Neil Sheerin Professor Simi Ali
| A C-terminal CXCL8 peptide based on chemokine-glycosaminoglycan interactions reduces neutrophil adhesion and migration during inflammation | 2019 |
|
Lucy Bates Professor Neil Sheerin
| A urinary microRNA panel that is an early predictive biomarker of delayed graft function following kidney transplantation | 2019 |
|
Dr Tracy Finch Dr Gregory Maniatopoulos Dr Chris Gibbins Professor Neil Sheerin Dr Suren Kanagasundaram et al. | Acute kidney injury electronic alerts: mixed methods Normalization Process Theory evaluation of their implementation into secondary care in England | 2019 |
|
Dr Jamie Willows Dr Ian Logan Professor Neil Sheerin Dr Charlie Tomson Dr Tim Ellam et al. | Changing Protein Permeability with Nephron Loss; Evidence for a Human Remnant Nephron Effect | 2019 |
|
Dr Mustafa Sevinc Susan Stamp David Talbot Professor Neil Sheerin
| Comparison of the outcome of kidney transplantation after pulsatile or continuous ex vivo hypothermic machine perfusion of kidneys donated after cardiac death: analysis of kidney pairs | 2019 |
|
Professor Neil Sheerin
| Eculizumab Prevents Thrombotic Microangiopathy in Patients With Atypical Hemolytic Uremic Syndrome in a Long-Term Observational Study | 2019 |
|
Professor Neil Sheerin
| Haemolytic uremic syndrome: diagnosis and management | 2019 |
|
Laura Ferreras Dr Anna Moles Fernandez Dr Aldi Situmorang Imogen Wilson Katie Cooke et al. | Heparan sulfate in chronic kidney diseases: exploring the role of 3-O-sulfation | 2019 |
|
Professor Fiona Oakley Lucy Gee Professor Neil Sheerin Dr Lee Borthwick
| Implementation of pre-clinical methodologies to study fibrosis and test anti-fibrotic therapy | 2019 |
|
Dr Aldi Situmorang Professor Neil Sheerin
| Ischaemia reperfusion injury: mechanisms of progression to chronic graft dysfunction | 2019 |
|
Professor Neil Sheerin
| Outcomes in Patients with Atypical Hemolytic Uremic Syndrome Treated with Eculizumab in a Long-term Observational Study | 2019 |
|
Dr Lu Wang Professor Andrew Fisher Professor Neil Sheerin Professor John Dark
| Severe acute kidney injury after cardiac transplantation is a marker of poor early outcome and impacts on late renal function -- a UK cohort study | 2019 |
|
Dr Edwin Wong Jo Stout Jalibani Ndebele Angela Watt Lisa Batchelor et al. | The Annual Report of the National Renal Complement Therapeutics Centre 2018/19 | 2019 |
|
Dr Lu Wang Dr Gareth Parry Professor Neil Sheerin Professor John Dark
| The need for haemofiltration after lung transplantation is a marker of poor early outcomes, but has no deleterious long-term renal effect -- a UK cohort study | 2019 |
|
Emily Glover Professor Neil Sheerin
| Urinary tract infection | 2019 |
|
Dr Emma Montgomery Professor Neil Sheerin
| Glomerular filtration rate: new age- and gender- specific reference ranges and thresholds for living kidney donation | 2018 |
|
Professor Neil Sheerin
| Long- and short-term outcomes in renal allografts with deceased donors: A large recipient and donor genome-wide association study | 2018 |
|
Emily Glover Nina Jordan Professor Neil Sheerin Professor Simi Ali
| Regulation of Endothelial-to-Mesenchymal Transition by MicroRNAs in Chronic Allograft Dysfunction | 2018 |
|
Dr Edwin Wong Jo Stout Jalibani Ndebele Angela Watt Dr Michal Malina et al. | The Annual Report of the National Renal Complement Therapeutics Centre 2017/18 | 2018 |
|
Victoria Shuttleworth Dr Luke Gaughan Lotfia Nawafa Professor Neil Sheerin Dr Ian Logan et al. | The methyltransferase SET9 regulates TGFB1 activation of renal fibroblasts via interaction with SMAD3 | 2018 |
|
Catriona Barker Sarah Thompson Dr Graeme O'Boyle Professor Neil Sheerin Professor Simi Ali et al. | CCL2 nitration is a negative regulator of chemokine-mediated inflammation | 2017 |
|
Dr Vicky Brocklebank Dr Sally Johnson Dr Patrick Walsh Dr Edwin Wong Dr Larissa Kerecuk et al. | Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland | 2017 |
|
Dr Jennifer Duff Professor Neil Sheerin Professor John Sayer Professor Gavin Hudson Professor Patrick Chinnery et al. | Mutations in mitochondrial DNA causing tubulointerstitial kidney disease | 2017 |
|
Professor Neil Sheerin
| Outcomes of patients with atypical haemolytic uraemic syndrome with native and transplanted kidneys treated with eculizumab: a pooled post hoc analysis | 2017 |
|
Sarah Thompson Beatriz Martinez Burgo Emeritus Professor John Kirby Professor Neil Sheerin Professor Simi Ali et al. | Regulation of chemokine function: The roles of GAG-binding and post-translational nitration | 2017 |
|
Dr Edwin Wong Dr Sally Johnson Professor Neil Sheerin Professor David Kavanagh
| The Annual Report of the National Renal Complement Therapeutics Centre 2016/2017 | 2017 |
|
Dr Amy Fearn Dr Aldi Situmorang Christopher Fox Professor Fiona Oakley Rachel Howarth et al. | The NF-kB1 is a key regulator of acute but not chronic renal injury | 2017 |
|
Professor Neil Sheerin Professor David Kavanagh Professor Tim Goodship Dr Sally Johnson
| A national specialised service in England for atypical haemolytic uraemic syndrome – the first year’s experience | 2016 |
|
Dr Suren Kanagasundaram Dr Andrew Sims Dr David Price Professor Neil Sheerin
| Computerised clinical decision support for the early recognition and management of acute kidney injury: a qualitative evaluation of end-user experience | 2016 |
|
Susan Stamp David Talbot Professor Neil Sheerin
| Ex Vivo Perfusion Characteristics of Donation After Cardiac Death Kidneys Predict Long-Term Graft Survival | 2016 |
|
Christopher Fox Dr Pasquale Cocchiaro Professor Fiona Oakley Rachel Howarth Krystena Callaghan et al. | Inhibition of lysosomal protease cathepsin D reduces renal fibrosis in murine chronic kidney disease | 2016 |
|
Beatriz Martinez Burgo Professor Simi Ali Jennifer Kirby Professor Neil Sheerin
| Ischemia-Reperfusion Injury Following Transplantation: Implications for the Modulation of CXCL8 Chemokine Function. | 2016 |
|
Professor Neil Sheerin
| Long-Term follow-up study of Eculizumab for prevention of thrombotic microangiopathy in patients with atypical hemolytic uremic syndrome | 2016 |
|
Dr Pasquale Cocchiaro Christopher Fox Rachel Howarth Dr Katrina Wood Professor Neil Sheerin et al. | Lysosomal Protease Cathepsin D, new player in apoptosis during acute kidney injury | 2016 |
|
Dr Pasquale Cocchiaro Christopher Fox Nicholas Tregidgo Rachel Howarth Dr Katrina Wood et al. | Lysosomal protease cathepsin D; a new driver of apoptosis during acute kidney injury | 2016 |
|
Professor Tim Goodship Professor Neil Sheerin
| Management of Recurrent aHUS After Adult Kidney transplantation Despite Eculizumab Prophylaxis. | 2016 |
|
Professor Neil Sheerin
| Renal Outcome with Eculizumab in Patients with aHUS with Native and Transplanted Kidneys: Pooled Analysis of 100 Patients. | 2016 |
|
Dr Gus Brooks Dr Aaron Liew Dr Helen Marshall Dr Ali Aldibbiat Professor Neil Sheerin et al. | De Novo Donor-Specific HLA Antibodies Are Associated With Rapid Loss of Graft Function Following Islet Transplantation in Type 1 Diabetes | 2015 |
|
Dr Isabel Pappworth Dr Edwin Wong Professor Neil Sheerin Professor Kevin Marchbank
| An extended mini-complement factor H molecule ameliorates experimental C3 glomerulopathy | 2015 |
|
Professor Neil Sheerin
| Behaviour of Transplanted Tumours and Role of Matching in Rejection | 2015 |
|
Amy Fearn Professor Neil Sheerin
| Complement activation in progressive renal disease | 2015 |
|
Professor Neil Sheerin
| Eculizumab Prevents Thrombotic Microangiopathy: Long-Term Follow-up Study of Patients with Atypical Hemolytic Uremic Syndrome | 2015 |
|
Professor Tim Goodship Professor Neil Sheerin
| Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies | 2015 |
|
Professor Neil Sheerin Dr Andrew Sims Dr David Price Dr Suren Kanagasundaram
| Electronic Clinical Decision Support for the Early Recognition and Management of Acute Kidney Injury: Qualitative Evaluation of End-User Experience | 2015 |
|
Dr Andrew Sims Professor Neil Sheerin Dr David Price Dr Suren Kanagasundaram
| Electronic clinical decision support for the early recognition and management of acute kidney injury: quantitative evaluation of outcomes | 2015 |
|
Dr Mustafa Sevinc Susan Stamp Dr Noel Carter Professor Neil Sheerin David Talbot et al. | Ex Vivo perfusion characteristics of DCD kidneys predict long-term graft survival | 2015 |
|
Dr Edwin Wong Dr Jeremy Palmer Professor Neil Sheerin Dr Isabel Pappworth
| FH1-5(18-20) ameliorates experimental C3 glomerulopathy; generation and testing of a murine version for further pre-clinical experiments | 2015 |
|
Dr Sarah McCloskey Professor Neil Sheerin
| From a fish tank injury to hospital haemodialysis: the serious consequences of drug interactions | 2015 |
|
Laura Ferreras Professor Neil Sheerin Emeritus Professor John Kirby Professor Simi Ali
| Mechanisms of renal graft chronic injury and progression to interstitial fibrosis | 2015 |
|
Dr Faryal Afridi Dr Rachael Coates Professor Neil Sheerin David Talbot
| Outcomes of ABOi Renal Transplants: A single centre experience over a seven year period | 2015 |
|
Dr Edwin Wong Rachel Challis Professor Neil Sheerin Dr Sally Johnson Professor David Kavanagh et al. | Patient stratification and therapy in atypical haemolytic uraemic syndrome (aHUS) | 2015 |
|
Christopher Fox Rachel Howarth Krystena Callaghan Dr Katrina Wood Professor Fiona Oakley et al. | Pepstatin A improves renal fibrosis by impairing UPA lysosomal recycling | 2015 |
|
Dr Luca Ermini Dr William Howell Professor Neil Sheerin
| Systematic assessment of the influence of complement gene polymorphisms on kidney transplant outcome | 2015 |
|
Dr Ian Logan Victoria Shuttleworth Dr Luke Gaughan Lotfia Nawafa Professor Neil Sheerin et al. | The Lysine Methyltransferase SETD7 is critical for TGF B-1 driven fibrosis | 2015 |
|
Professor Tim Goodship Dr Alison Brown Professor Neil Sheerin
| Thrombotic microangiopathy as a cause of chronic kidney transplant dysfunction: a case report demonstrating successful treatment with Eculizumab | 2015 |
|
Dr Caroline Wilson Dr Lindsay Murphy Jack Leslie Dr Stuart Kendrick Jeremy French et al. | Ubiquitin C-terminal hydrolase 1: A novel functional marker for liver myofibroblasts and a therapeutic target in chronic liver disease | 2015 |
|
Professor Neil Sheerin
| Urinary tract infection | 2015 |
|
Professor Neil Sheerin Dr Judith Hall Rob Pickard
| E. coli inhibits innate immunity to facilitate pyelonephritic infections | 2014 |
|
Professor David Kavanagh Professor Neil Sheerin
| Management of hemolytic uremic syndrome | 2014 |
|
Dr James Frith Professor Fai Ng Professor Chris Day Dr Brendan Payne Professor Neil Sheerin et al. | Orthostatic intolerance is common in chronic disease - A clinical cohort study | 2014 |
|
Professor Neil Sheerin
| Prognosis and management of chronic kidney disease (CKD) at the end of life | 2014 |
|
Professor Neil Sheerin
| Thrombotic microangiopathies | 2014 |
|
Dr Ian Logan Professor Neil Sheerin
| Anticoagulation and kidney injury: rare observation or common problem? | 2013 |
|
Professor Simi Ali Professor Neil Sheerin
| Biomarkers of acute injury: predicting the long-term outcome after transplantation | 2013 |
|
Professor Neil Sheerin
| Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocol | 2013 |
|
Professor Tim Goodship Professor Neil Sheerin
| Efficacy of Eculizumab in atypical hemolytic uremic syndrome (aHUS) patients with or without prior transplant | 2013 |
|
Dr Edwin Wong Mark Brady Professor Neil Sheerin
| Severe intestinal oedema due to nephrotic syndrome | 2013 |
|
Professor Neil Sheerin Professor Tim Goodship
| Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome | 2013 |
|
Dr Luca Ermini Professor Tim Goodship Dr Lisa Turnbull Professor Heather Cordell Dr Veronique Fremaux-Bacchi et al. | Common genetic variants in complement genes other than CFH, CD46 and the CFHRs are not associated with aHUS. | 2012 |
|
Dr Luca Ermini Dr Ian Wilson Professor Tim Goodship Professor Neil Sheerin
| Complement polymorphisms: Geographical distribution and relevance to disease | 2012 |
|
Dr Valerie Wilson Dr Iain Moore Dr Lisa Turnbull Professor Kevin Marchbank Professor Neil Sheerin et al. | Postpartum aHUS Secondary to a Genetic Abnormality in Factor H Acquired Through Liver Transplantation | 2012 |
|
Dr Eva-Maria Hunze Professor Neil Sheerin Professor Kevin Marchbank
| Targeting the glomerular basement membrane to control unwanted complement activation | 2012 |
|
Dr Amy Fearn Professor Neil Sheerin
| Complement activation drives interstitial inflammation and fibrosis in models of kidney disease | 2011 |
|
Dr Luca Ermini Professor Tim Goodship Dr Lisa Turnbull Professor Heather Cordell Dr Veronique Fremaux-Bacchi et al. | Genetic variants in CFH and CD46 are the major susceptibility factors for aHUS-An association study of multiple complement genes | 2011 |
|
Dr Ellen Hatch Professor Louise Parker Emeritus Professor John Kirby Professor Neil Sheerin
| Infiltrating renal T cells are activated and respond to self antigen | 2011 |
|
Dr Alison Brown Professor Tim Goodship Professor Neil Sheerin Professor Derek Manas
| Successful Treatment of De Novo Posttransplant Thrombotic Microangiopathy With Eculizumab | 2011 |
|
Dr Amy Fearn Dr Steven Lisgo Dr Steven Darby Professor Neil Sheerin
| The influence of complement activation on chronic renal inflammation and fibrosis | 2011 |
|
Dr Amy Fearn Dr Steven Lisgo Dr Steven Darby Professor Neil Sheerin
| The influence of complement activation on chronic renal inflammation and fibrosis | 2011 |
|
Professor Neil Sheerin
| Trajectories of Illness in Stage 5 Chronic Kidney Disease: A Longitudinal Study of Patient Symptoms and Concerns in the Last Year of Life | 2011 |
|
Professor Neil Sheerin
| Endogenous Ligands for TLR2 and TLR4 Are Not Involved in Renal Injury following Ureteric Obstruction | 2010 |
|
Dr Amy Fearn Professor Neil Sheerin
| Pivotal role of CD4+ T cells in renal fibrosis following ureteric obstruction | 2010 |
|
Dr Amy Fearn Professor Neil Sheerin
| The influence of complement activation on chronic renal inflammation and fibrosis | 2010 |
|
Professor Neil Sheerin
| A Novel Role for Nephrin in the Maintenance of Glomerular Structure | 2009 |
|
Dr Ellen Hatch Professor Neil Sheerin
| C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy | 2009 |
|
Professor Neil Sheerin
| Complement activation and progression of chronic kidney disease | 2009 |
|
Dr V Ingham Professor Neil Sheerin
| Diabetic glomerular disease: Pitfalls in diagnosis | 2009 |
|
Emerita Professor Julia Newton Professor Neil Sheerin
| Fatigue in early renal disease | 2009 |
|
Professor Neil Sheerin
| Illness trajectories: an important concept in the management of kidney failure | 2009 |
|
Dr Amy Fearn Professor Neil Sheerin
| Role for CD4+ T cells in Renal Fibrosis | 2009 |
|
Professor Neil Sheerin
| Synergy between type 1 fimbriae expression and C3 opsonisation increases internalisation of E-coli by human tubular epithelial cells | 2009 |
|
Dr Amy Fearn Professor Fiona Oakley Professor Derek Mann Professor Neil Sheerin
| Tubulointerstitial inflammation and fibrosis is not influenced by deficiency of the regulatory transcription factor NFκB1 | 2009 |
|
Dr Amy Fearn Professor Fiona Oakley Professor Derek Mann Professor Neil Sheerin
| Tubulointerstitial inflammation and fibrosis is not influenced by deficiency of the regulatory transcription factor NFκB1 | 2009 |
|
Professor Neil Sheerin
| Understanding Symptoms in Patients with Advanced Chronic Kidney Disease Managed without Dialysis: Use of a Short Patient-Completed Assessment Tool | 2009 |
|
Professor Neil Sheerin
| Dialysis or not? A comparative survival study of patients over 75 years of age with chronic kidney disease stage - Reply | 2008 |
|
Dr Daniela Lee Professor Neil Sheerin
| Paranoid Psychosis and Myoclonus: Flecainide Toxicity in Renal Failure | 2008 |
|
Professor Neil Sheerin
| Reimplantation of the ureter after unilateral ureteral obstruction provides a model that allows functional evaluation | 2008 |
|
Professor Neil Sheerin
| Reply | 2008 |
|
Professor Neil Sheerin
| Should Complement Activation Be a Target for Therapy in Renal Transplantation? | 2008 |
|
Professor Neil Sheerin
| Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury | 2008 |
|
Professor Neil Sheerin
| The classical complement pathway plays a critical role in the opsonisation of uropathogenic Escherichia coli | 2008 |
|
Professor Neil Sheerin
| Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5 | 2007 |
|
Professor Neil Sheerin
| Mechanisms of disease: the complement system in renal injury - new ways of looking at an old foe | 2007 |
|
Professor Neil Sheerin
| Accumulation of Immune Complexes in Glomerular Disease Is Independent of Locally Synthesized C3 | 2006 |
|
Professor Neil Sheerin
| CD46 (Membrane Cofactor Protein) Acts as a Human Epithelial Cell Receptor for Internalization of Opsonized Uropathogenic Escherichia coli | 2006 |
|
Professor Neil Sheerin
| Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection | 2006 |
|
Professor Neil Sheerin
| Influence of Donor C3 Allotype on Late Renal-Transplantation Outcome | 2006 |
|
Professor Neil Sheerin
| Toll-like receptors TLR2 and TLR4 initiate the innate immune response of the renal tubular epithelium to bacterial products | 2006 |
|
Professor Neil Sheerin
| Mycobacterium simiae: a previously undescribed pathogen in peritoneal dialysis peritonitis | 2005 |
|
Dr Muhammad Khan Professor Neil Sheerin
| Urinary tract infections: new insights into a common problem | 2005 |
|
Professor Neil Sheerin
| Autoimmune renal injury in C3- and C4-deficient mice: a histological and functional study | 2004 |
|
Dr Zahed Chowdhury Professor Neil Sheerin
| Minireview: functions of the renal tract epithelium in coordinating the innate immune response to infection | 2004 |
|
Professor Neil Sheerin
| The membrane attack complex, C5b-9, up regulates collagen gene expression in renal tubular epithelial cells | 2004 |
|
Professor Neil Sheerin
| Urinary tract infections: advances and new therapies | 2004 |
|
Professor Neil Sheerin
| Positron emission tomography in a patient with renal malacoplakia | 2003 |
|
Professor Neil Sheerin
| Leaked protein and interstitial damage in the kidney: is complement the missing link? | 2002 |
|
Professor Neil Sheerin
| Epithelial secretion of C3 promotes colonization of the upper urinary tract by Escherichia coli | 2001 |
|
Professor Neil Sheerin
| Late allograft loss due to recurrence of p-ANCA-associated systemic vasculitis in a patient with relapsing polychondritis | 2001 |
|
Professor Neil Sheerin
| Protection and injury: the differing roles of complement in the development of glomerular injury | 2001 |
|
Professor Neil Sheerin
| Spontaneous Abdominal Hemorrhage with AA-amyloidosis and Vasculitis in a Patient with Rheumatoid Arthritis | 2001 |
|
Professor Neil Sheerin
| Successful medical treatment of acute bilateral emphysematous pyelonephritis | 2000 |
|
Professor Neil Sheerin Michael Carroll
| Altered distribution of intraglomerular immune complexes in C3-deficient mice | 1999 |
|
Professor Neil Sheerin
| Apical Proteins Stimulate Complement Synthesis by Cultured Human Proximal Tubular Epithelial Cells | 1999 |
|
Professor Neil Sheerin
| Chronic Interstitial Damage in Proteinuria. Does Complement Mediate Tubulointerstitial Injury? | 1999 |
|
Professor Neil Sheerin
| Contribution of renal secreted complement C3 to the circulating pool in humans | 1999 |
|
Professor Neil Sheerin
| In vitro erythrophagocytosis by renal tubular cells and tubular toxicity by haemoglobin and iron | 1999 |
|